ARTICLE | Management Tracks
Plus: Will Kane named CCO, Venkat Ramanan CFO of Anthos, and an update from Breath Diagnostics
By Gunjan Ohri, Data Content Analyst
November 1, 2024 10:27 PM UTC
FDA named Amy Rick director of strategic coalitions for the newly established Rare Disease Innovation Hub, which will serve as a point of contact for the rare disease community and coordinate research. Rick was a principal consultant at Leavitt Partners and president and CEO of Food and Drug Law Institute.
Cardiovascular metabolic disease company Anthos Therapeutics Inc. named Will Kane president and chief commercial officer, and Venkat Ramanan CFO. Kane was CCO at Karuna Therapeutics Inc. and Ramanan was CFO of Turnstone Biologics Corp. (NASDAQ:TSBX)…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654054/amy-rick-joins-fda-s-newly-formed-rare-disease-innovation-hub